期刊
CHEMICAL COMMUNICATIONS
卷 50, 期 78, 页码 11523-11525出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c4cc05558f
关键词
-
资金
- Swiss National Science Foundation [PP00P2_133568]
- University of Zurich
- Stiftung fur Wissenschaftliche Forschung of the University of Zurich
- L. & Th. La Roche Stiftung
Zr-89-based imaging agents hold great promise as novel radio-tracers in nuclear medicine. However, insufficient stability of currently used radiometal complexes in vivo is a safety concern for clinical applications. We herein report the first octadentate bifunctional chelating agent for the development of Zr-89-labelled (bio) conjugates with improved stability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据